# Multicenter, Prospective Study to Determine the Performance and Safety of the New M-HA30 Architect Device on the Quality of the Skin: HEBE8 Study

> **NCT07007351** · NA · COMPLETED · sponsor: **Laboratoires FILLMED** · enrollment: 285 (actual)

## Conditions studied

- Skin Aging

## Interventions

- **DEVICE:** Intradermal injection

## Key facts

- **NCT ID:** NCT07007351
- **Lead sponsor:** Laboratoires FILLMED
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-19
- **Primary completion:** 2024-04-13
- **Final completion:** 2024-06-13
- **Target enrollment:** 285 (ACTUAL)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07007351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07007351, "Multicenter, Prospective Study to Determine the Performance and Safety of the New M-HA30 Architect Device on the Quality of the Skin: HEBE8 Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07007351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*